share_log
Reuters ·  Apr 29 07:00
Prime Medicine Announces FDA Clearance of Investigational New Drug (Ind) Application for Pm359 for the Treatment of Chronic Granulomatous Disease (Cgd)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment